Pacific Biosciences Of California reported $18.76M in Cost of Sales for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cost Of Sales Change
Accelerate Diagnostics AXDX:US USD 2.19M 591K
Agilent A:US USD 837M 58M
Bruker BRKR:US USD 303.8M 14.9M
Danaher DHR:US USD 3.43B 351M
Fluidigm FLDM:US USD 16.43M 2.08M
General Electric GE:US USD 15.88B 1.22B
Illumina ILMN:US USD 398M 3M
Myriad Genetics MYGN:US USD 50.4M 700K
Nanostring Technologies NSTG:US USD 13.72M 2.13M
Pacific Biosciences Of California PACB:US USD 18.76M 510K
Perkinelmer PKI:US USD 304.76M 258.65M
Roche Holding ROG:VX 9.56B 717M
Thermo Fisher Scientific TMO:US USD 6.72B 340M
Waters WAT:US USD 307.1M 105K